EverSource Wealth Advisors LLC Grows Stake in The Cooper Companies, Inc. (NASDAQ:COO)

EverSource Wealth Advisors LLC grew its position in The Cooper Companies, Inc. (NASDAQ:COO) by 337.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,347 shares of the medical device company’s stock after purchasing an additional 4,125 shares during the quarter. EverSource Wealth Advisors LLC’s holdings in Cooper Companies were worth $543,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Benjamin F. Edwards & Company Inc. grew its holdings in shares of Cooper Companies by 248.6% during the first quarter. Benjamin F. Edwards & Company Inc. now owns 244 shares of the medical device company’s stock valued at $25,000 after buying an additional 174 shares during the last quarter. Covestor Ltd grew its holdings in shares of Cooper Companies by 305.9% during the first quarter. Covestor Ltd now owns 276 shares of the medical device company’s stock valued at $28,000 after buying an additional 208 shares during the last quarter. Global Retirement Partners LLC grew its holdings in shares of Cooper Companies by 358.6% during the first quarter. Global Retirement Partners LLC now owns 321 shares of the medical device company’s stock valued at $33,000 after buying an additional 251 shares during the last quarter. Blue Trust Inc. lifted its position in Cooper Companies by 54.8% during the fourth quarter. Blue Trust Inc. now owns 96 shares of the medical device company’s stock valued at $36,000 after purchasing an additional 34 shares during the period. Finally, Clearstead Trust LLC acquired a new position in Cooper Companies during the first quarter valued at $36,000. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Stock Down 1.0 %

Shares of COO traded down $0.93 during midday trading on Friday, reaching $93.27. The stock had a trading volume of 880,304 shares, compared to its average volume of 1,253,850. The Cooper Companies, Inc. has a 1-year low of $75.93 and a 1-year high of $104.07. The company’s fifty day simple moving average is $91.03 and its two-hundred day simple moving average is $94.21. The company has a market cap of $18.57 billion, a price-to-earnings ratio of 54.78, a PEG ratio of 2.34 and a beta of 0.98. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.95 and a quick ratio of 1.14.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, May 30th. The medical device company reported $0.85 earnings per share for the quarter, beating analysts’ consensus estimates of $0.83 by $0.02. The business had revenue of $942.60 million for the quarter, compared to analyst estimates of $948.07 million. Cooper Companies had a net margin of 9.11% and a return on equity of 8.87%. The company’s revenue was up 7.4% on a year-over-year basis. During the same period last year, the business earned $0.77 EPS. Equities research analysts expect that The Cooper Companies, Inc. will post 3.57 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Piper Sandler reiterated an “overweight” rating and issued a $115.00 price objective on shares of Cooper Companies in a research report on Wednesday, July 3rd. Jefferies Financial Group upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating and upped their price objective for the stock from $107.00 to $115.00 in a research report on Tuesday, July 16th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research report on Friday, May 31st. Finally, Robert W. Baird upped their price objective on shares of Cooper Companies from $116.00 to $118.00 and gave the stock an “outperform” rating in a research report on Friday, May 31st. Four research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $111.78.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.